We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Genetic Abnormality Predicts Benefit from Treatment for a Rare Brain Tumor

News   Jan 20, 2012

 
Genetic Abnormality Predicts Benefit from Treatment for a Rare Brain Tumor
 
 
Advertisement
 

RELATED ARTICLES

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News

UK charity LifeArc has awarded Vicore Pharma approximately £1.5 million for the ATTRACT VP01 (C21) COVID-19 study.

READ MORE

DNA Analysis From Ancient Bronze Age Individuals

News

A new study has found that the DNA of Canaanites is a mixture of two populations: The Chalcolithic Zagros and Early Bronze Age Caucasus.

READ MORE

Study Explores How Ketamine Works Against Depression

News

The anesthetic drug ketamine administered in low doses, has been shown to help treat difficult-to-treat depression. A research team has now identified a key target for the drug – specific serotonin receptors in the brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE